Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study.
Journal Information
Full Title: Br J Clin Pharmacol
Abbreviation: Br J Clin Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"COMPETING INTERESTS Michel J.A.M. van Putten is co‐founder of Clinical Science Systems, Leiden, The Netherlands. All other authors declare no conflict of interest."
"Funding information Stichting Life Sciences Holland (LSH) ‐ TKI, Health~Holland, under LSH Match, Grant/Award Number: LSHM16055‐SGF"
"This study was approved by the Ethics Committee Stichting Beoordeling Ethiek Biomedisch Onderzoek, Assen, The Netherlands. The trial was executed in accordance to the Declaration of Helsinki at the Centre for Human Drug Research (CHDR), Leiden, The Netherlands, between September 2017 and February 2018. The study is registered in the Dutch Trial Registry (NTR) under NL6638."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025